Economic evaluation of encorafenib with cetuximab in patients with BRAF V600E-mutant metastatic colorectal cancer in France: a cost-effectiveness analysis using data from the BEACON CRC randomised controlled trial
Trouiller, Jean-Baptiste, Macabeo, Bérengère, Poll, Andrew, Howard, Dan, Buckland, Andy, Sivignon, Marine, Clay, Emilie, Malka, David, Samalin, Emmanuelle, Toumi, Mondher, Laramée, Philippe
Published in BMJ open (21.11.2022)
Published in BMJ open (21.11.2022)
Get full text
Journal Article
Public health impact of COVID-19 in French ambulatory patients with at least one risk factor for severe disease
Millier, Aurélie, Supiot, Romain, Benyounes, Kelly, Machuron, Valérie, Le Lay, Katell, Sivignon, Marine, Leboucher, Claire, Blein, Cécile, Raffi, François
Published in Journal of market access & health policy (31.12.2022)
Published in Journal of market access & health policy (31.12.2022)
Get full text
Journal Article
Valuation of Treatments for Rare Diseases: A Systematic Literature Review of Societal Preference Studies
Dabbous, Omar, Chachoua, Lylia, Aballéa, Samuel, Sivignon, Marine, Persson, Ulf, Petrou, Stavros, Richardson, Jeff, Simoens, Steven, Toumi, Mondher
Published in Advances in therapy (01.02.2023)
Published in Advances in therapy (01.02.2023)
Get full text
Journal Article
Cost-effectiveness of atezolizumab versus docetaxel and nivolumab in the treatment of non-small cell lung cancer as a second line in France
Marine, Sivignon, Stéphane, Roze, Nicolas, Plommet, Felizzi, Federico, Paracha, Noman, Benjamin, Mazaleyrat, Perol, Maurice
Published in Journal of medical economics (03.05.2020)
Published in Journal of medical economics (03.05.2020)
Get full text
Journal Article